Children with neuroblastomas may benefit from new drug cocktail

Children who develop neuroblastomas, a rare form of cancer which develops in nerve cells, may benefit from receiving certain anti-tumor drugs as well as chemotherapy, a new trial has found.

Home-Based Care Software: Why Partnerships are Key to Success

Luke Rutledge, Chief Commercial Officer at Homecare Homebase The home-based care sector is undergoing a significant surge in demand. As more patients choose the comfort

July 24, 2024

Psychedelic Study: LSD Microdosing Improves Sleep

The TDR Three Key Takeaways regarding Psychedelic Studies and LSD Microdosing: LSD microdosing highlighted as a promising sleep enhancer in new study. Experimental evidence points

April 22, 2024

ChromaDex wins orphan designation for rare ataxia drug – Pharmaceutical Technology

Ataxia telangiectasia is a rare, inherited, progressive childhood disorder for which symptoms manifest neurologically and immunologically. Chromadex is developing a candidate to treat ataxia telangiectasia.

June 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.